sEphB4-alb treatment led to tumor regression while control mice showed steady increase in the BLI (average 8.96E + 02 in sEphB4-alb group versus average 9.11E + 07 in control group after 24 weeks) (Fig. 4a and b, Supplementary Fig. 6). Here, ALB is linked to neoplasm.